“Individualized approach to high-risk therapy: comparative assessment of fixed and separate combinations of antihypertensive and hypolipidemic drugs”, Je, vol. 1, no. 2, pp. 122–131, Jun. 2024, doi: 10.70626/3060-4850-2024-1-2-101-110.